(Q43966538)

28 November 2017

title

Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations (English)

1 reference

28 November 2017

1 reference

Wever AM

1

1 reference

28 November 2017

Wever-Hess J

series ordinal

2

1 reference

28 November 2017

Hensgens HE

series ordinal

3

1 reference

28 November 2017

Hermans J

series ordinal

4

1 reference

28 November 2017

publication date

1 September 1994

1 reference

28 November 2017

1 reference

28 November 2017

volume

88

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

613-621

1 reference

28 November 2017

cites work

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Airway mucosal inflammation even in patients with newly diagnosed asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Eosinophils in exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season†

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980010-1

7 January 2021

10.1016/S0954-6111(05)80010-1

Identifiers

DOI

1 reference

28 November 2017

1 reference